Metraipolis › archive › dc_6ef9bc281f55

Atractylenolide III for central nervous system disorders: a review of multi-target mechanisms and therapeutic potential — Europe PMC PMID:42292848

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42292848
DOI
10.3389/fphar.2026.1799976
License (as archived)
solo-consultazione
Archived
2026-11-01T04:07:35.889Z
SHA-256 of the archived text
68f0cc274b0d8720fbf8e18a057f90f5b9ec3364aedb54839e538ac84769a71d
Stable URL of this page
https://metraipolis.com/documento/dc_6ef9bc281f55

How to cite

Atractylenolide III for central nervous system disorders: a review of multi-target mechanisms and therapeutic potential — Europe PMC PMID:42292848 — Europe PMC (en), https://europepmc.org/article/MED/42292848 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6ef9bc281f55 (Metraipolis archive dc_6ef9bc281f55, sha256 68f0cc274b0d8720fbf8e18a057f90f5b9ec3364aedb54839e538ac84769a71d)
BibTeX
@misc{dc6ef9bc281f55,
  title = {Atractylenolide III for central nervous system disorders: a review of multi-target mechanisms and therapeutic potential — Europe PMC PMID:42292848},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42292848},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6ef9bc281f55; sha256 68f0cc274b0d8720fbf8e18a057f90f5b9ec3364aedb54839e538ac84769a71d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42292848. Agents can read the archived copy with the MCP tool read_document.